[1]陈丽珍,黄祯,杨银广,等.彩色多普勒超声对颈动脉中度狭窄患者阿托伐他汀强化治疗后颈动脉斑块厚度及体积的评价*[J].陕西医学杂志,2018,(11):1454-1456.
　Chen Lizhen,Huang Zhen,Yang Yinguang,et al.Using improved statin treatment of unstable plaques in carotid artery moderate stenosis before and after ultrasonic image contrast research[J].,2018,(11):1454-1456.
点击复制

彩色多普勒超声对颈动脉中度狭窄患者阿托伐他汀强化治疗后颈动脉斑块厚度及体积的评价*
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2018年11期
页码:
1454-1456
栏目:
临床研究
出版日期:
2018-11-29

文章信息/Info

Title:
Using improved statin treatment of unstable plaques in carotid artery moderate stenosis before and after ultrasonic image contrast research
文章编号:
0.3969/j.issn.1000-7377.2018.11.026
作者:
陈丽珍; 黄祯; 杨银广; 陆伟恒
广东省东莞市第三人民医院（东莞523320）
Author(s):
Chen Lizhen; Huang Zhen; Yang Yinguang; et al.
Third People’s Hospital of Dongguan City in Guangdong Province（Dongguan 523320）
关键词:
颈动脉狭窄阿托伐他汀超声检查;  多普勒;  彩色
Keywords:
Carotid stenosisAtorvastatinUltrasonography;  doppler;  color
分类号:
R445.1
文献标志码:
A
摘要:
目的：研究对比使用强化阿托伐他汀治疗不稳定斑块导致的颈动脉中度狭窄前后颈动脉斑块厚度以及体积的变化。方法：选取由不稳定斑块导致的颈动脉中度狭窄患者40例。所有患者均予以阿托伐他汀治疗，40 mg/d，连续治疗3个月。对比患者治疗前后各项血脂指标水平情况，同时采用超声检查患者颈动脉斑块厚度以及斑块体积情况，并检测患者丙氨酸氨基转移酶（ALT）、天门冬氨酸氨基转移酶（AST）、肌酸激酶（CK）以及肌酐（Cr）水平。结果：治疗后患者总胆固醇与低密度脂蛋白胆固醇水平分别为（4.29±1.18）mmol/L、（2.63±1.01）mmol/L，均显著低于治疗前的（4.94±1.44）mmol/L、（3.16±1.30）mmol/L（均P＜0.05）。治疗后患者颈动脉斑块厚度以及斑块体积分别为（1.20±0.31）mm、（42.55±4.51）mm3，均显著低于治疗前的（1.46±0.53）mm、（72.14±8.52）mm3（均P＜0.05）。治疗前后患者AST、ALT、CK以及Cr水平对比差异无统计学意义（均P＞0.05）。结论：阿托伐他汀强化治疗不稳定斑块导致的颈动脉中度狭窄效果较佳，可显著改善患者血脂水平，且安全性较好。而超声图像可有效反映患者治疗前后颈动脉斑块变化情况，可用以作为临床预后评估指标。
Abstract:
Objective：To study the contrast using improved statin treatment of unstable plaques in carotid artery ultrasound images and analyzed before and after moderate stenosis.Methods：Chose caused by unstable plaques of carotid artery in 40 patients with moderate stenosis.All patients were given atorvastatin treatment, 40 mg/d, continuous treatment for 3 months.Contrast before and after treatment in patients with blood lipid index level, at the same time using ultrasound in patients with carotid artery plaque thickness and volume,and detect the AST, ALT, CK, and patients with Cr level.Results：After treatment in patients with total cholesterol and low density lipoprotein cholesterol respectively was (4.29±1.18) mmol/L,(2.63±1.01) mmol/L, were significantly lower than before treatment (4.94±1.44) mmol/L, (3.16±1.30) mmol/L (all P＜0.05).After treatment in patients with carotid artery plaque thickness and plaque volume (1.20±0.31) mm,(42.55±4.51) mm3, were significantly lower than before treatment (1.46±1.46) mm, after (72.14±8.52) mm3 (all P＜0.05).Before and after treatment in patients with AST,ALT,CK and Cr level contrast was not obvious (P ＞0.05).Conclusion：Atorvastatin treatment effect of unstable plaques in carotid artery moderate stenosis is better, can significantly improve patients with blood lipid levels, and better security.And ultrasound images can effectively reflect the changes before and after treatment in patients with carotid artery plaque, can be used as a clinical prognostic indicators.

参考文献/References:

[1] Wan MYS,Endozo R,Michopoulou S,et al.PET/CT Imaging of Unstable Carotid Plaque with 68Ga-Labeled Somatostatin Receptor Ligand[J].J Nucl Med,2017,58(5)：774-780.
[2]王珅,方庆娟,武星,等.丁苯酞软胶囊对缺血性脑血管病患者颈动脉硬化的抗炎作用及斑块稳定性的影响[J].海南医学院学报,2017,23(7)：946-949.
[3]张优佳,高茜,吴三妮,等.阿托伐他汀钙在高血压患者抗动脉粥样硬化治疗中的临床疗效观察[J].中国现代药物应用,2013,7(21)：17-18.
[4]邱洁,曹爱红,张萍,等.葡萄籽原花青素联合阿托伐他汀治疗老年颈动脉粥样硬化患者的观察[J].中华老年医学杂志,2012,31(5)：371-375.
[5]白雪,王欢,杨思进,等.蛭龙活血通瘀胶囊对颈动脉狭窄患者粥样硬化斑块的影响[J].云南中医中药杂志,2017,38(2)：31-34.
[6]汪素莉.颈动脉超声下初发性和复发性脑梗死患者颈动脉粥样硬化的表现对比[J].检验医学与临床,2017,14(6)：872-874.
[7]Dilsizian V, Jadvar H.Science to Practice: Does FDG Differentiate Morphologically Unstable from Stable AtheroscleroticPlaque[J].Radiology，2017,283(1)：1-3.
[8]夏永梅,于玲,李兰君,等.阿托伐他汀联合氯吡格雷及拜阿司匹林对进展性脑梗死患者颈动脉粥样硬化的疗效评价[J].蚌埠医学院学报,2016,41(3)：337-339.
[9]王超,杨少华,徐风亮,等.经双源CT检查颈动脉斑块性质与血清超敏C反应蛋白、脂蛋白a、同型半胱氨酸水平的相关性分析[J].中国医师进修杂志,2015,38(6)：410-413.
[10]齐珊珊,付赵虎,白炜玮,等.普罗布考联合阿托伐他汀对大动脉源性脑梗死患者血液黏度、TCD 指标及颈动脉斑块稳定性的影响[J].心血管康复医学杂志,2017,26(1):86-90.
[11]王跃慧,田跃雷,梁文华,等.阿司匹林联合阿托伐他汀对缺血性脑血管病患者血清ox-LDL、炎性因子和颈动脉斑块的影响[J].河北医药,2016,38(11):1628-1631.
[12]解冰川,刘惠苗,时军,等.20 mg阿托伐他汀钙对无症状颈动脉不稳定斑块患者hsCRP、MMP-9的影响[J].河北医科大学学报,2016,37(7):753-756.
[13]王龙安,韩涵,崔维,等.高分辨率磁共振评价阿托伐他汀钙对颈动脉硬化不稳定斑块的影响[J].中国实用神经疾病杂志,2017,20(8)：12-14.
[14]雷春香,李奎光.高频多普勒超声在阿托伐他汀治疗颈动脉粥样硬化疗效观察中的应用[J].当代医学,2012,18(13)：45-46.
[15]彭文宏,陈兆芸,邓彦,等.阿托伐他汀联合拜阿司匹林对缺血性脑卒中患者颈部动脉斑块的影响[J].中国实用医刊,2017,44(4):13-15.
[16]熊静芳,傅国胜,任宏宇,等.阿托伐他汀联合拜阿司匹林对缺血性脑卒中患者颈动脉斑块及卒中复发的影响[J].浙江中西医结合杂志,2016,26(4)：311-313.
[17]吴威.盐酸小檗碱联合阿托伐他汀治疗急性脑梗死的疗效及对颈动脉粥样硬化斑块的影响[J].中国老年学杂志,2016,36(18)：4459-4460.
[18]高菊华,高小平,赵志鸿,等.颈动脉粥样硬化斑块中亲环素A/CDI47表达及阿托伐他汀干预的影响[J].中南大学学报：医学版,2016,41(5)：482-488.

相似文献/References:

[1]付晓娟,刘明盛,吴晓兰.彩色多普勒超声对凶险性前置胎盘合并植入的诊断价值研究*[J].陕西医学杂志,2018,(11):1417.
　Fu Xiaojuan,Liu Mingsheng,Wu Xiaolan..The diagnosis and clinical value of color doppler ultrasound in prenatal diagnosis of dangerous placenta previa combined with implantation[J].,2018,(11):1417.

备注/Memo

备注/Memo:
*广东省东莞市科技计划医疗卫生类项目（201510515000699）
更新日期/Last Update: 2018-11-30